Mechanisms of miR-195-5p and FOXK1 in rat xenograft models of non-small cell lung cancer

被引:1
|
作者
Niu, Jiguo [1 ]
Wang, Yiwen [2 ]
Hu, Yonghua [3 ]
Li, Caili [4 ]
Fang, Yue [5 ]
机构
[1] Gansu Prov Canc Hosp, Dept Nucl Med, Lanzhou 730050, Gansu, Peoples R China
[2] Gansu Prov Canc Hosp, Dept Clin Lab, 2 Xiaoxihu East St, Lanzhou 730050, Gansu, Peoples R China
[3] Gansu Univ Chinese Med, Lanzhou 730000, Gansu, Peoples R China
[4] Northwest Minzu Univ, Sch Med, Lanzhou 730030, Gansu, Peoples R China
[5] Gansu Prov Hosp TCM, Lanzhou 730050, Gansu, Peoples R China
来源
关键词
Non-small cell lung cancer; miR-195-5p; FOXK1; mechanism; STATISTICS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the roles and mechanisms of miR-195-5p and forkhead box K1 (FOXK1) in rat xenograft models of non-small cell lung cancer (NSCLC). Methods: Rat xenograft models of NSCLC were established. Evaluations of morphology of NSCLC cells and levels of Ki67 and P53 were detected by hematoxylin-eosin (HE) staining and immunohistochemistry (IHC), respectively. The miR-195-5p level in NSCLC was measured by quantitative real-time RT-PCR (qRT-PCR), and FOXK1, Bax, Caspase-3 and Bal-2 levels were quantified by Western blot. And the regulatory relation between miR-195-5p and FOXK1 was determined by dual-luciferase reporter (DLR) assay. Results: HE staining and IHC demonstrated successful establishment of NSCLC models in which miR-195-5p was downregulated and FOXK1 was upregulated. Pearson correlation showed that miR-195-5p and FOXK1 were inversely associated (r=0.551, P=0.012). DLR assay confirmed the targeted regulatory relation between miR-195-5p and FOXK1, and upregulation of miR-195-5p accelerated apoptosis of tumor cells. Conclusion: miR-195-5p is inversely associated with FOXK1 in NSCLC in rats. Upregulation of miR-195-5p suppresses FOXK1 and accelerates apoptosis of tumor cells, which may serve as an therapeutic target for the treatment of NSCLC.
引用
收藏
页码:2528 / 2536
页数:9
相关论文
共 50 条
  • [31] Estrogen Promotes Resistance to Bevacizumab Treatment in Non-Small Cell Lung Cancer (NSCLC) Xenograft Models
    Patel, S.
    Herynk, M.
    Cascone, T.
    Saigal, B.
    Nilsson, M.
    Tran, H.
    Ramachandran, S.
    Minna, J.
    Wistuba, I.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S564 - S565
  • [32] Establishment of patients' primary non-small cell lung cancer xenograft models for test of anticancer drugs
    Liu, Changnian
    Sun, Daqiang
    Li, Wenwei
    Zhou, Wen
    He, Fang
    Zhou, Rui
    Zhang, Xun
    CANCER RESEARCH, 2012, 72
  • [33] miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas
    Queiroz, Andre Lima
    Zhang, Boxi
    Comstock, Dawn E.
    Hao, Yuqing
    Eriksson, Matilda
    Hydbring, Per
    Vakifahmetoglu-Norberg, Helin
    Norberg, Erik
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 499 (02) : 314 - 320
  • [34] Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer
    Tian, Fei
    Shen, Yanting
    Chen, Zhenzhu
    Li, Rui
    Lu, Jiafeng
    Ge, Qinyu
    GENE, 2016, 591 (02) : 338 - 343
  • [35] Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer
    Zhu, Jianjie
    Zeng, Yuanyuan
    Xu, Chun
    Qin, Hualong
    Lei, Zhe
    Shen, Dan
    Liu, Zeyi
    Huang, Jian-An
    ONCOLOGY REPORTS, 2015, 34 (04) : 1779 - 1786
  • [36] MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1
    Ye, Ming-fan
    Lin, Dong
    Li, Wu-jin
    Xu, Hai-peng
    Zhang, Jing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7131 - 7142
  • [37] RETRACTED ARTICLE: The lncRNA XIST promotes colorectal cancer cell growth through regulating the miR-497-5p/FOXK1 axis
    Nan Wang
    Jia-Xing He
    Guo-Zhan Jia
    Ke Wang
    Shuai Zhou
    Tao Wu
    Xian-Li He
    Cancer Cell International, 20
  • [38] miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells
    Yan, Liang
    Ma, Jinzhu
    Wang, Yi
    Zan, Jiawei
    Wang, Zhen
    Zhu, Yu
    Zhu, Yiping
    Ling, Liefeng
    Cao, Long
    Liu, Xin
    Li, Shu
    Xu, Lei
    Qi, Zhilin
    Nie, Liuwang
    Zhang, Yao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4655 - 4663
  • [39] Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapy
    Traber, Gavin M.
    Tu, Mei-Juan
    Guan, Su
    Batra, Neelu
    Yu, Ai-Ming
    MOLECULAR PHARMACOLOGY, 2025, 107 (01)
  • [40] Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/beta-catenin signaling pathway
    Zhang, Chan
    Huang, Jian
    Lou, Ke
    Ouyang, Hui
    CANCER MEDICINE, 2022, 11 (07): : 1589 - 1604